Task: Answer the MCQ question.
Query: Which drug exhibits a 0.874\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCC(C)Sc1nc2c(cnn2-c2ccc(C)c(C)c2)c(=O)[nH]1
b) CCN(CC)c1ncnc2sc3c(c12)CCC3.Cl
Answer: a. CCC(C)Sc1nc2c(cnn2-c2ccc(C)c(C)c2)c(=O)[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)Sc1nc2c(cnn2-c2ccc(C)c(C)c2)c(=O)[nH]1
CCC(C)Sc1nc2c(cnn2-c2ccc(C)c(C)c2)c(=O)[nH]1
6-butan-2-ylsulfanyl-1-(3,4-dimethylphenyl)-5H-pyrazolo[3,4-d]pyrimidin-4-one